A cost-consequences analysis of the effect of pregabalin in the treatment of peripheral neuropathic pain in routine medical practice in primary care settings.

This was mainly a consequence of higher significant reductions in means number of days working with pain, rather than a substantial increase of labour productivity or reduction of days of absenteeism which, nevertheless, showed a trend toward statistical significance in favour of groups treated with PGB (table 4 ).

also in 53,322 other papers